↓ Skip to main content

Bifidobacteria: their impact on gut microbiota composition and their applications as probiotics in infants

Overview of attention for article published in Applied Microbiology and Biotechnology, November 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

blogs
1 blog
twitter
10 X users
patent
5 patents

Citations

dimensions_citation
155 Dimensions

Readers on

mendeley
334 Mendeley
Title
Bifidobacteria: their impact on gut microbiota composition and their applications as probiotics in infants
Published in
Applied Microbiology and Biotechnology, November 2013
DOI 10.1007/s00253-013-5405-9
Pubmed ID
Authors

Diana Di Gioia, Irene Aloisio, Giuseppe Mazzola, Bruno Biavati

Abstract

This review is aimed at describing the most recent advances in the gut microbiota composition of newborns and infants with a particular emphasis on bifidobacteria. The newborn gut microbiota is quite unstable, whereas after weaning, it becomes more stable and gets closer to the typical adult microbiota. The newborn and infant gut microbiota composition is impaired in several enteric and non-enteric pathologies. The core of this review is the description of the most recent documented applications of bifidobacteria to newborns and infants for their prevention and treatment. Acute diarrhea is the most studied disease for which bifidobacteria are applied with great success, Bifidobacterium longum and Bifidobacterium breve being the most applied species. Moreover, the most recent updates in the use of bifidobacteria for the prevention and treatment of pathologies typical of newborns, such as necrotizing enterocolitis, colics, and streptococcal infections, are presented. In addition, a number of not strictly enteric pathologies have in recent years evidenced a strict correlation with an aberrant gut microbiota in infants, in particular showing a reduced level of bifidobacteria. These diseases represent new potential opportunities for probiotic applications. Among them, allergic diseases, celiac disease, obesity, and neurologic diseases are described in this review. The preliminary use of bifidobacteria in in vitro systems and animal models is summarized as well as preliminary in vivo studies. Only after validation of the results via human clinical trials will the potentiality of bifidobacteria in the prevention and cure of these pathologies be definitely assessed.

X Demographics

X Demographics

The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 334 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 <1%
United Kingdom 2 <1%
Malaysia 1 <1%
Brazil 1 <1%
Latvia 1 <1%
Italy 1 <1%
Japan 1 <1%
Denmark 1 <1%
Greece 1 <1%
Other 1 <1%
Unknown 322 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 55 16%
Student > Master 53 16%
Student > Ph. D. Student 49 15%
Student > Bachelor 43 13%
Student > Doctoral Student 18 5%
Other 44 13%
Unknown 72 22%
Readers by discipline Count As %
Agricultural and Biological Sciences 76 23%
Medicine and Dentistry 55 16%
Biochemistry, Genetics and Molecular Biology 42 13%
Immunology and Microbiology 20 6%
Nursing and Health Professions 17 5%
Other 38 11%
Unknown 86 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 25. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 August 2022.
All research outputs
#1,404,438
of 24,119,703 outputs
Outputs from Applied Microbiology and Biotechnology
#77
of 8,034 outputs
Outputs of similar age
#16,015
of 315,791 outputs
Outputs of similar age from Applied Microbiology and Biotechnology
#2
of 86 outputs
Altmetric has tracked 24,119,703 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,034 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 315,791 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 86 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.